← Back

Dirui Industrial Co Ltd

Dirui Industrial Co., Ltd. researches, develops, produces, and sells medical instruments and related reagents and test strips in the People's Republic of China. Its offerings include urine analysis, biochemical analysis, chemiluminescence immunoassay, gynecological secretion analysis, blood cell analysis, coagulation analysis, and integrated laboratory solutions. The company was founded in 1992 and is headquartered in Changchun, the People's Republic of China.

Price · split & dividend adjusted
News & notes moving 300396.CS
300396.CS

ST Dirui Announces Change of Employee Representative Director; Zhang Xuelong Succeeds Liu Kang

ST Dirui announced on September 16 that Liu Kang would no longer serve as the company's employee representative director due to work reasons, and would continue to serve as deputy general manager and chief financial officer. On the same day, the company held an employee representative assembly and elected Zhang Xuelong as employee representative director, with a term lasting until the expiry of the sixth board of directors. In the first half of 2026, ST Dirui achieved revenue of 409 million yuan and net profit attributable to the parent company of 7.6 million yuan.
财中社·3dRead more →
300396.CS6

ST Dirui swings to profit in 2026 interim report with net profit of 7.60 million yuan

ST Dirui released its 2026 interim report, with net profit attributable to the parent company of 7.60 million yuan, swinging to profit year-on-year, an increase of 35.91 million yuan compared with the same period last year. The company's total operating revenue was 409 million yuan, up 16.49 percent year-on-year. Net cash outflow from operating activities was 114 million yuan, the asset-liability ratio fell to 39.73 percent, and gross margin rose for three consecutive quarters to 45.35 percent.
Jiemian·45dRead more →